US8470859B2
(en)
*
|
2006-10-23 |
2013-06-25 |
Takeda Pharmaceutical Company Limited |
Iminopyridine derivative and use thereof
|
US7638541B2
(en)
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
WO2009014910A2
(en)
|
2007-07-19 |
2009-01-29 |
Metabolex, Inc. |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders
|
US8481569B2
(en)
*
|
2008-04-23 |
2013-07-09 |
Takeda Pharmaceutical Company Limited |
Iminopyridine derivatives and use thereof
|
CA2723216C
(en)
*
|
2008-04-23 |
2017-01-24 |
Takeda Pharmaceutical Company Limited |
Iminopyridine derivatives and use thereof
|
US20110039892A1
(en)
*
|
2008-04-23 |
2011-02-17 |
Takeda Pharmaceutical Company Limited |
Iminopyridine derivative and use thereof
|
AU2013206248B2
(en)
*
|
2008-06-27 |
2016-06-23 |
Xenon Pharmaceuticals Inc. |
Organic compounds
|
EP2344474B1
(en)
*
|
2008-09-02 |
2015-09-23 |
Novartis AG |
Picolinamide derivatives as kinase inhibitors
|
AU2011265439B2
(en)
*
|
2008-09-02 |
2012-09-20 |
Novartis Ag |
Picolinamide derivatives as kinase inhibitors
|
EP2370424A1
(en)
|
2008-11-10 |
2011-10-05 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
EP4059932A1
(en)
|
2008-12-19 |
2022-09-21 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
EP2373163B1
(en)
*
|
2008-12-19 |
2015-06-10 |
Genentech, Inc. |
Heterocyclic compounds and methods of use
|
JO2885B1
(en)
|
2008-12-22 |
2015-03-15 |
ايلي ليلي اند كومباني |
Protein kinase inhibitors
|
EP2424843B1
(en)
*
|
2009-04-30 |
2014-03-26 |
Novartis AG |
Imidazole derivatives and their use as modulators of cyclin dependent kinases
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
ES2497566T3
(es)
|
2009-10-01 |
2014-09-23 |
Cymabay Therapeutics, Inc. |
Sales de tetrazol-1-il-fenoximetil-tiazol-2-il-piperidinil-pirimidina sustituida
|
BR112012018897A2
(pt)
*
|
2010-01-27 |
2017-10-03 |
Ab Pharma Ltd |
Compostos poli-heterocíclicos altamente potentes como inibidores de hcv
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
KR101464060B1
(ko)
|
2010-04-07 |
2014-11-20 |
에프. 호프만-라 로슈 아게 |
피라졸-4-일-헤테로사이클릴-카복사마이드 화합물 및 사용 방법
|
EP2569286B1
(en)
|
2010-05-12 |
2014-08-20 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
EP2568984A1
(en)
|
2010-05-12 |
2013-03-20 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
WO2011143425A2
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
JP5856151B2
(ja)
|
2010-05-12 |
2016-02-09 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Atrキナーゼ阻害剤として有用な2−アミノピリジン誘導体
|
AU2011253025A1
(en)
|
2010-05-12 |
2012-11-29 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
WO2011143419A1
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Pyrazines useful as inhibitors of atr kinase
|
EP2627650A2
(en)
|
2010-05-26 |
2013-08-21 |
Merck Sharp & Dohme Corp. |
N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
|
WO2011163090A1
(en)
|
2010-06-23 |
2011-12-29 |
Metabolex, Inc. |
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
US8623869B2
(en)
|
2010-06-23 |
2014-01-07 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
WO2012004217A1
(en)
*
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Cyclic ether compounds useful as kinase inhibitors
|
US9056832B2
(en)
|
2010-09-17 |
2015-06-16 |
Purdue Pharma L.P. |
Pyridine compounds and the users thereof
|
AR083339A1
(es)
|
2010-10-05 |
2013-02-21 |
Purdue Pharma Lp |
Compuestos de quinazolina como bloqueadores de los canales de sodio
|
US8987307B2
(en)
*
|
2011-03-03 |
2015-03-24 |
Hoffmann-La Roche Inc. |
3-amino-pyridines as GPBAR1 agonists
|
UY33930A
(es)
*
|
2011-03-04 |
2012-10-31 |
Novartis Ag |
Inhibidores novedosos de quinasas
|
CA2832100A1
(en)
|
2011-04-05 |
2012-10-11 |
Vertex Pharmaceuticals Incorporated |
Aminopyrazine compounds useful as inhibitors of tra kinase
|
US8822469B2
(en)
|
2011-06-22 |
2014-09-02 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase
|
WO2012178125A1
(en)
|
2011-06-22 |
2012-12-27 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
WO2012178124A1
(en)
|
2011-06-22 |
2012-12-27 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
CN102924444B
(zh)
*
|
2011-08-11 |
2015-07-08 |
上海吉铠医药科技有限公司 |
Pim激酶抑制剂及其制备方法与在制药中的应用
|
EP2755482B1
(en)
*
|
2011-09-15 |
2016-06-01 |
Merck Sharp & Dohme Corp. |
Combination of mk-1775 and mk-8776 for treating cancer
|
WO2013045461A1
(en)
|
2011-09-27 |
2013-04-04 |
F. Hoffmann-La Roche Ag |
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
US20130089626A1
(en)
|
2011-09-30 |
2013-04-11 |
Vertex Pharmaceuticals Incorporated |
Treating Cancer with ATR Inhibitors
|
WO2013049720A1
(en)
|
2011-09-30 |
2013-04-04 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
CA2850564A1
(en)
|
2011-09-30 |
2013-04-04 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
US8765751B2
(en)
|
2011-09-30 |
2014-07-01 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
ES2751741T3
(es)
|
2011-09-30 |
2020-04-01 |
Vertex Pharma |
Procedimiento para fabricar compuestos útiles como inhibidores de la quinasa ATR
|
WO2013071090A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
US8846918B2
(en)
|
2011-11-09 |
2014-09-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
EP2776419B1
(en)
|
2011-11-09 |
2016-05-11 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
WO2013071088A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
WO2013071093A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
BR112014013136B1
(pt)
*
|
2011-11-30 |
2020-05-26 |
F. Hoffmann-La Roche Ag |
Novos derivados de dihidroisoquinolina-1-ona biciclicos
|
IN2014KN02410A
(es)
|
2012-04-05 |
2015-05-01 |
Vertex Pharma |
|
CN104334546B
(zh)
|
2012-05-21 |
2017-05-03 |
诺华股份有限公司 |
作为激酶抑制剂的新的环‑取代的n‑吡啶基酰胺
|
CN104755471A
(zh)
|
2012-08-30 |
2015-07-01 |
日本新药株式会社 |
吡啶衍生物及药物
|
US8999632B2
(en)
|
2012-10-04 |
2015-04-07 |
Vertex Pharmaceuticals Incorporated |
Method for measuring ATR inhibition mediated increases in DNA damage
|
US8912198B2
(en)
|
2012-10-16 |
2014-12-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
LT3418281T
(lt)
|
2012-12-07 |
2021-01-11 |
Vertex Pharmaceuticals Inc. |
Pirazolo[1,5-a]pirimidinai, naudotini kaip atr kinazės inhibitoriai, skirti vėžinių ligų gydymui
|
CN103058913B
(zh)
*
|
2012-12-13 |
2015-09-30 |
江苏弘和药物研发有限公司 |
5-氯异吲哚酮的合成方法
|
CA2897200C
(en)
|
2013-01-14 |
2021-07-06 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
|
LT2945939T
(lt)
|
2013-01-15 |
2020-07-27 |
Incyte Holdings Corporation |
Triazolkarboksamidai ir piridinkarboksamido junginiai, naudotini kaip pim kinazės inhibitoriai
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
US9663519B2
(en)
|
2013-03-15 |
2017-05-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
MY182082A
(en)
|
2013-05-01 |
2021-01-18 |
Hoffmann La Roche |
Biheteroaryl compounds and uses thereof
|
WO2014181813A1
(ja)
*
|
2013-05-10 |
2014-11-13 |
武田薬品工業株式会社 |
複素環化合物
|
TW201605866A
(zh)
|
2013-08-23 |
2016-02-16 |
英塞特公司 |
可用作pim激酶抑制劑之呋喃并-及噻吩并-吡啶甲醯胺化合物
|
JP2016536364A
(ja)
|
2013-11-05 |
2016-11-24 |
バイエル・クロップサイエンス・アクチェンゲゼルシャフト |
節足動物を防除するための新規化合物
|
KR102153886B1
(ko)
|
2013-12-06 |
2020-09-09 |
버텍스 파마슈티칼스 인코포레이티드 |
Atr 키나제 억제제로서 유용한 2-아미노-6-플루오로-n-[5-플루오로-피리딘-3-일]피라졸로[1,5-a]피리미딘-3-카복스아미드 화합물, 이의 제조 방법, 이의 상이한 고체형 및 방사성표지된 유도체
|
US10730866B2
(en)
*
|
2014-04-07 |
2020-08-04 |
Purdue Pharma L.P. |
Indole derivatives and use thereof
|
PT3152212T
(pt)
|
2014-06-05 |
2020-03-13 |
Vertex Pharma |
Derivados radiomarcados de um composto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útil como inibidor de atr quinase, preparação do dito composto e diferentes formas sólidas do mesmo
|
RU2736219C2
(ru)
|
2014-06-17 |
2020-11-12 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ лечения рака с использованием комбинации ингибиторов снк1 и atr
|
WO2016010897A1
(en)
|
2014-07-14 |
2016-01-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
JO3589B1
(ar)
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
WO2016024350A1
(ja)
*
|
2014-08-13 |
2016-02-18 |
株式会社エス・ディー・エス バイオテック |
縮合11員環化合物及びそれらを含有する農園芸用殺菌剤
|
UY36294A
(es)
|
2014-09-12 |
2016-04-29 |
Novartis Ag |
Compuestos y composiciones como inhibidores de quinasa
|
WO2016127074A1
(en)
|
2015-02-06 |
2016-08-11 |
Blueprint Medicines Corporation |
2-(pyridin-3-yl)-pyrimidine derivatives as ret inhibitors
|
WO2016196244A1
(en)
|
2015-05-29 |
2016-12-08 |
Incyte Corporation |
Pyridineamine compounds useful as pim kinase inhibitors
|
EP3322706B1
(en)
|
2015-07-16 |
2020-11-11 |
Array Biopharma, Inc. |
Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
|
AR105967A1
(es)
|
2015-09-09 |
2017-11-29 |
Incyte Corp |
Sales de un inhibidor de pim quinasa
|
KR20180054657A
(ko)
|
2015-09-30 |
2018-05-24 |
버텍스 파마슈티칼스 인코포레이티드 |
Dna 손상제 및 atr 저해제의 병용물을 사용한 암 치료 방법
|
TW201718546A
(zh)
|
2015-10-02 |
2017-06-01 |
英塞特公司 |
適用作pim激酶抑制劑之雜環化合物
|
JP2018534296A
(ja)
|
2015-10-26 |
2018-11-22 |
ロクソ オンコロジー, インコーポレイテッドLoxo Oncology, Inc. |
Trk阻害薬耐性がんにおける点変異およびそれに関連する方法
|
IL302209B1
(en)
|
2015-11-02 |
2024-02-01 |
Blueprint Medicines Corp |
RET inhibitors
|
PL3415496T3
(pl)
|
2016-02-08 |
2022-02-07 |
Gowan Crop Protection Limited |
Sposób przygotowania związku 1,2-benzenodimetanolu
|
AU2016392652B2
(en)
|
2016-02-08 |
2021-01-21 |
Gowan Company, L.L.C. |
Fungicidal Composition
|
KR20180129911A
(ko)
|
2016-04-04 |
2018-12-05 |
록쏘 온콜로지, 인코포레이티드 |
소아암을 치료하는 방법
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
MX2018012163A
(es)
|
2016-04-04 |
2019-07-08 |
Loxo Oncology Inc |
Formulaciones liquidas de (s)-n-(5-((r)-2-(2,5-difluorofenil)-pirr olidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidina- 1-carboxamida.
|
CN107286134B
(zh)
*
|
2016-04-11 |
2019-04-12 |
上海勋和医药科技有限公司 |
2,4-二取代嘧啶衍生物作为cdk抑制剂及其应用
|
RS61463B1
(sr)
|
2016-05-18 |
2021-03-31 |
Loxo Oncology Inc |
Priprema (s)-n-(5-((r)-2-(2,5-difluorofenil)pirolidin-1-il)pirazolo[1,5-a]pirimidin-3-il) -3-hidroksipirolidin-1-karboksamida
|
US10227329B2
(en)
|
2016-07-22 |
2019-03-12 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
WO2018022761A1
(en)
|
2016-07-27 |
2018-02-01 |
Blueprint Medicines Corporation |
Substituted cyclopentane-amides for treating disorders related to ret
|
AU2017305392A1
(en)
|
2016-08-03 |
2019-02-21 |
Cymabay Therapeutics, Inc. |
Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
|
US20180072718A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
JOP20190077A1
(ar)
|
2016-10-10 |
2019-04-09 |
Array Biopharma Inc |
مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
ES2878078T3
(es)
*
|
2016-11-28 |
2021-11-18 |
Bristol Myers Squibb Co |
Inhibidores de GSK-3
|
ES2850773T3
(es)
|
2016-11-28 |
2021-08-31 |
Bristol Myers Squibb Co |
Piridincarboxamidas como inhibidores de GSK-3
|
EP3571203B1
(en)
|
2017-01-18 |
2023-06-07 |
Array BioPharma Inc. |
Substituted pyrazolo[1,5-a]pyrazine compounds as ret kinase inhibitors
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
EP3461480A1
(en)
|
2017-09-27 |
2019-04-03 |
Onxeo |
Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
|
TWI812649B
(zh)
|
2017-10-10 |
2023-08-21 |
美商絡速藥業公司 |
6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
|
TWI791053B
(zh)
|
2017-10-10 |
2023-02-01 |
美商亞雷生物製藥股份有限公司 |
6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物
|
AU2018352695A1
(en)
|
2017-10-19 |
2020-05-28 |
Effector Therapeutics, Inc. |
Benzimidazole-indole inhibitors of Mnk1 and Mnk2
|
CN107641095A
(zh)
*
|
2017-11-16 |
2018-01-30 |
常州合全药业有限公司 |
一种7‑甲氧基异吲哚‑1‑酮的合成方法
|
AR113922A1
(es)
|
2017-12-08 |
2020-07-01 |
Incyte Corp |
Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas
|
CA3087578C
(en)
|
2018-01-18 |
2023-08-08 |
Array Biopharma Inc. |
Substituted pyrazolo[3,4-d]pyrimidine compounds as ret kinase inhibitors
|
CN111615514B
(zh)
|
2018-01-18 |
2022-10-11 |
奥瑞生物药品公司 |
作为ret激酶抑制剂的取代的吡唑并[4,3-c]吡啶化合物
|
TWI802635B
(zh)
|
2018-01-18 |
2023-05-21 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡咯并[2,3-d]嘧啶化合物
|
IL276779B2
(en)
*
|
2018-02-20 |
2024-04-01 |
Incyte Corp |
Derivatives and related compounds of N-(phenyl)-2-(phenyl)pyrimidine-4-carboxamide as HPK1 inhibitors for cancer treatment
|
JP7268049B2
(ja)
|
2018-03-08 |
2023-05-02 |
インサイト・コーポレイション |
PI3K-γ阻害剤としてのアミノピラジンジオール化合物
|
SI3773589T1
(sl)
|
2018-04-03 |
2024-03-29 |
Blueprint Medicines Corporation |
Inhibitor RET za uporabo pri zdravljenju raka, ki ima RET spremembo
|
WO2020010003A1
(en)
|
2018-07-02 |
2020-01-09 |
Incyte Corporation |
AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
|
CA3224949A1
(en)
|
2018-07-31 |
2020-02-06 |
Loxo Oncology, Inc. |
Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1h-pyrazole-4-carboxamide
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
WO2020046975A1
(en)
*
|
2018-08-29 |
2020-03-05 |
Seal Rock Therapeutics, Inc. |
Methods of treating neurodegenerative diseases
|
ES2922314T3
(es)
|
2018-09-10 |
2022-09-13 |
Array Biopharma Inc |
Compuestos heterocíclicos condensados como inhibidores de cinasa RET
|
US11142525B2
(en)
*
|
2018-11-15 |
2021-10-12 |
Pfizer Inc. |
Azalactam compounds as HPK1 inhibitors
|
WO2020131674A1
(en)
|
2018-12-19 |
2020-06-25 |
Array Biopharma Inc. |
7-((3,5-dimethoxyphenyl)amino)quinoxaline derivatives as fgfr inhibitors for treating cancer
|
WO2020131627A1
(en)
|
2018-12-19 |
2020-06-25 |
Array Biopharma Inc. |
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases
|
PE20221419A1
(es)
|
2019-08-06 |
2022-09-20 |
Incyte Corp |
Formas solidas de un inhibidor de hpk1
|
KR20220123023A
(ko)
|
2019-12-27 |
2022-09-05 |
슈뢰딩거, 인크. |
시클릭 화합물 및 이의 사용 방법
|
CN111592533B
(zh)
*
|
2020-06-16 |
2021-08-24 |
浙江工业大学 |
1,2,4-噁二唑联吡啶取代苯甲酰胺类化合物及其制备方法和应用
|
JP2023541047A
(ja)
|
2020-09-10 |
2023-09-27 |
シュレーディンガー, インコーポレイテッド |
がんの治療のための複素環式ペリ縮環cdc7キナーゼ阻害剤
|
WO2022164789A1
(en)
|
2021-01-26 |
2022-08-04 |
Schrödinger, Inc. |
Tricyclic compounds useful in the treatment of cancer, autoimmune and inflammatory disoders
|
TW202300150A
(zh)
|
2021-03-18 |
2023-01-01 |
美商薛定諤公司 |
環狀化合物及其使用方法
|
PE20240767A1
(es)
*
|
2021-04-16 |
2024-04-17 |
Hotspot Therapeutics Inc |
Compuestos, composiciones y metodos para el tratamiento de trastornos
|
WO2023030478A1
(zh)
*
|
2021-09-03 |
2023-03-09 |
浙江海正药业股份有限公司 |
吡啶并内酰胺类衍生物及其制备方法和用途
|
WO2023088435A1
(zh)
*
|
2021-11-19 |
2023-05-25 |
成都奥睿药业有限公司 |
三取代吡啶衍生物的制备及作为芳香烃受体调节物的应用
|
WO2023250399A1
(en)
*
|
2022-06-22 |
2023-12-28 |
Tempest Therapeutics, Inc. |
Trex1 inhibitors and uses thereof
|